Showing results (1-10 of 3,097) with videos related to

Sort By:
Pageof 310
Future Medicinal Chemistry|August 21, 2025
Recent advances in small molecules targeting the METTL3Feifei Wu, Lei Yu, Shilin Xu
Expert Opinion on Therapeutic Patents|January 8, 2026
A patent review of KDM4 histone demethylase inhibitors (2014-present)Xiaolong Yang, Yuyan Han, Lei Yu, et al.
European Journal of Medicinal Chemistry|February 20, 2025
Discovery of a first-in-class PROTAC degrader of histone lysine demethylase KDM4Danni Rao, Yiting Wang, Xiaolong Yang, et al.
Journal of Medicinal Chemistry|January 2, 2025
Targeting QPCTL: An Emerging Therapeutic OpportunityLei Yu, Yaoliang Sun, Longyan Xie, et al.
European Journal of Medicinal Chemistry|June 19, 2022
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferaseYaoliang Sun, Ying Zhang, Xiaoai Chen, et al.
European Journal of Medicinal Chemistry|April 16, 2023
Discovery of 7H-Pyrrolo[2,3-d]pyrimidine Derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitorsFeifei Wu, Huiyu Li, Qi An, et al.
Bioorganic & Medicinal Chemistry|June 10, 2025
Design, synthesis and structure-activity relationship studies of novel macrocyclic 2,4-diaminopyrimidines as HPK1 inhibitorsFeifei Wu, Jiaqi Sun, Mingyang Xu, et al.
Cell Chemical Biology|January 9, 2024
Discovery of a PROTAC degrader for METTL3-METTL14 complexWenhao Du, Yuting Huang, Xiaoai Chen, et al.
Pageof 310